Because life depends on us™
5th BSMA Europe
Annual Conference
La Hulpe (Brussels), Belgium
NOVEMBER 12, 2020
BSMA AWARDS PROMOTION INFORMATION
3rd BSCA Conference – SSF, 2010
BIOTECH INDUSTRY LEADERS FROM AROUND THE WORLD WILL GATHER IN
SOUTH SAN FRANCISCO, CALIFORNIA, TO ADDRESS IMPROVING THE GLOBAL
SUPPLY CHAIN TO MAXIMIZE PATIENT CARE
San Francisco, California (March 20, 2010): The world’s leading community for biotechnology supply chain professionals will be meeting at the Embassy Suites in South San Francisco on October 26, 2010, for the 3rd annual Biotech Supply Chain Academy conference. The expanded multi-track conference titled “Transforming the Global Supply Chain for End-to-End Visibility and Quality Patient Care” will be identifying and developing supply chain solutions for the industry’s expanding world presence with a clear focus on patient care. The Call for Papers requests expert speakers to present on topics enumerated below and others deemed pertinent and valuable. The deadline for paper submissions is August 1, 2010.
Industry and Academia leaders from around the world will present a large slate of sessions designed to increase collaboration and cooperation between suppliers, manufacturers, distributors, and providers. The focus of the conference will be the Top 10 issues facing the biotech industry:
-
Biotech Industry Research from Wall Street, Venture Capital and Manufacturing Industry Experts
-
Development of Supply Chain Talent Management: Practices from the Best in Other Industries and Academia
-
Creating the Patient-focused Supply Chain: Best Practices for the Identification, Measurement, and Execution of Risk Management
-
Information Technology Management: The Holy Grail! Technical Solutions to Enable Procure to Pay and ePedigree
-
Global Strategic Sourcing: Sourcing Development Strategies in a Collaborative Environment to Maximize Supplier and Vendor Relationships
-
Visibility in the Supply Chain: Proven Solutions from End-to-End
-
Cash Management: Ensuring the Financial Bottom Line of SCM
-
Applying Lean Six Sigma and QA to Optimize Patient Care and Eliminate Waste
-
Cold Chain & Logistics Management: Technologies and Best of Breed Case Studies
-
CRO, CMO, R&D and Business Analytics Services: The New Outsourcing Frontiers of India, China and Europe
“The executive and academic leaders of the biotech industry have built a strong foundation for the discussion of challenges, exchange of solutions, and implementation of advancements in the supply chain in an open, collaborative manner,” says Devendra Mishra, the executive director of the Bio Supply Management Alliance (BSMA) and adjunct professor of Pepperdine University’s Graziadio School of Business & Management. “Today they are committed to fostering the mission of improving the efficacy of the end-to-end supply chain by reducing the drug development pipeline cost and time line through global synergies and developing highly capable supply chain management talent for higher quality patient care.”
2010 Conference Program
Location: South San Francisco
Untitled Document
7:30-8:30
REGISTRATION/GOLDEN GATE BALLROOM
8:30-8:35
WELCOME: Devendra Mishra, Executive Director,Bio Supply Management Association (BSMA)
8:35-9:00
KEYNOTE: Healthcare – Prospering in a Post-reform World
One of the most important pieces of health legislation since Medicare is now the law of the land. This presentation will discuss the impact to the value chain stakeholders and suggestions for their blueprint to derive long-term value. Healthcare value chain executives (providers, payers, retailers, distributors, and life sciences) will have to work quickly to position their organizations for the post-reform world to respond to the challenge of new taxes, new regulations, and new administrative deadlines.
Karen Conway, Director – Industry Programs, Global Health Exchange (GHX)
9:00-9:30
Uncovering the Unique Competencies of the Top 25 Healthcare Companies
The first AMR Research Healthcare Top 25 for 2009 recognizes those life sciences and healthcare companies – manufacturers, distributors, pharmacies and hospitals, which have demonstrated leadership in developing and leveraging supply chain capabilities. The Bottom Line: Johnson & Johnson, one of the world’s foremost healthcare companies, is No. 1, followed by Sisters of Mercy, a hospital system that is leading the way for supply chain transformation at the patient level. The secrets of their success will be identified along with best practices and strategies deployed as Healthcare companies must stem the cost of incoming supplies and deal with decreasing reimbursement for their products and services.
Wayne McDonnell, Research Director, Healthcare & Life Science, Gartner
9:30-10:15
PANEL: Industry 360° – Transforming The Industry End To End
Stakeholders of the industry – Manufacturers, Wholesale Distributors, Retail Pharmacies, Hospitals and Healthcare Providers, discuss challenges, exchange solutions and collaborate to advance the supply chain in terms of productivity, quality, customer service and technology. Other salient issues of linkage of manufacturers with providers, outsourcing,
distribution network design and management, logistics strategies and best practice will be addressed.
Panelists:
Alison Moore, Vice President Corporate Manufacturing, Amgen
Andy Ramelmeier, Vice President, Manufacturing and Process Development, Bio-Marin
Chris Horan, Vice President, Supply Chain, North America, Genentech
Doug Witter, Vice President, Sales and Marketing, OM Healthcare Logistics, Owens & Minor HealthCare
Jason Birnbaum, CIO, GE Global Supply Chain, GE Healthcare
Vance Moore, President and CEO, Resource Optimization and Innovation (Sisters of Mercy)
Moderator: Wayne McDonnell, Research Director. Life Sciences, Gartner
10:15-10:30
NETWORKING BREAK SPONSORED BY BAYER HEALTHCARE – BALLROOM
10:30-11:00
Working Capital Management in the Global Enterprise: The Bottom Line!
Management of working capital inventory, assets, receivables and payables, is a vital imperative of business. Presentation will address the challenges and solutions of optimization in a global, volatile network of manufacturing,
distribution and retail. Implementation of forecasting systems, measurement techniques, metrics, visibility and management dash boards will be discussed.
Thomas Panzer, Vice President Global Supply Chain PS-Biotech, Bayer Healthcare
11:00-11:30
KEYNOTE: Single-source, Integrated Supply Chain Services for Healthcare
As an operating division of the Sisters of Mercy Health System, ROi is one of the healthcare industry’s leading single-source, fully-integrated supply chain management companies, providing purchasing, product and pharmaceutical distribution services, and custom procedure tray manufacturing. Presentation covers how technology and the principles of collaboration, innovation, alignment and service improve the clinical, operational and financial strength of its customers. Mercy/ROi was recognized as the National Award Winner for the 2010 Search for Supply Chain Excellence Award conducted by AMR Research.
Vance Moore, President and CEO, Resource Optimization & Innovation (Sisters of Mercy)
11:30-12:00
Transforming Enterprise Level Supply Chain of Biological Entities
This session will describe an enterprise-class biological entity management system Infosys has co-created with a bio-pharmaceutical client to accelerate the biologics research, and streamline the innovation process. This system enables
biologists to register biological entities uniquely, manage associated processes, track inventory effectively, request and fulfill stock efficiently, and also enhance tracking and tracing of intellectual property related to such
entities. It will bring together scientists from different parts of the research value chain and in different sites, reduce redundancies in research transactions, accelerate the innovation processes, and lower operational costs dramatically.
R. Arun Kumar, Industry Head-Global Life Sciences, Infosys
12:00-1:15
NETWORKING LUNCH – Ballroom
12:30-1:00
Special Presentation: California ePedigree: the Legal Requirements
Background and Contours of the California Electronic Pedigree Requirements – Existing Law, Timelines for Implementation, and Next Steps.
Joshua Room, Deputy Attorney General, California Department of Justice, Office of the Attorney General
5:00-5:30
Keynote: Biotech Industry Supply Chain: A Vision of the Future With a Blueprint for Results
Based on a situational analysis of the industry with recognition of the points of inflexion and the thought leadership at the Conference, a road map will be provided for major initiatives to positively impact the supply chain which the stakeholders can implement through collaboration.
Speaker
Dave Malenfant
Vice-President
Global Supply Chain
Alcon Laboratories
5:30-7:00
Track 1-Ballroom
1:15-1:45 Progression From Tactical Purchasing to Strategic Sourcing
As the biopharmaceutical industry has grown and evolved, its procurement practices have essentially stalled in the tactical purchasing mode, with most companies focused on how to be more efficient with issuing purchase orders, managing contracts and issuing one-way supplier assessments. A proven case study will be presented of strategic sourcing and category management to address significant cost savings, partnerships for product development and launch, and supply risk management.
Speaker
Paul Anderson
Vice President
Global Procurement LifeTechnologies
As the biopharmaceutical industry has grown and evolved, its procurement practices have essentially stalled in the tactical purchasing mode, with most companies focused on how to be more efficient with issuing purchase orders, managing contracts and issuing one-way supplier assessments. A proven case study will be presented of strategic sourcing and category management to address significant cost savings, partnerships for product development and launch, and supply risk management.
Speaker
Paul Anderson
Vice President
Global Procurement LifeTechnologies
As the biopharmaceutical industry has grown and evolved, its procurement practices have essentially stalled in the tactical purchasing mode, with most companies focused on how to be more efficient with issuing purchase orders, managing contracts and issuing one-way supplier assessments. A proven case study will be presented of strategic sourcing and category management to address significant cost savings, partnerships for product development and launch, and supply risk management.
Speaker
Paul Anderson
Vice President
Global Procurement LifeTechnologies
As the biopharmaceutical industry has grown and evolved, its procurement practices have essentially stalled in the tactical purchasing mode, with most companies focused on how to be more efficient with issuing purchase orders, managing contracts and issuing one-way supplier assessments. A proven case study will be presented of strategic sourcing and category management to address significant cost savings, partnerships for product development and launch, and supply risk management.
Speaker
Paul Anderson
Vice President
Global Procurement LifeTechnologies
As the biopharmaceutical industry has grown and evolved, its procurement practices have essentially stalled in the tactical purchasing mode, with most companies focused on how to be more efficient with issuing purchase orders, managing contracts and issuing one-way supplier assessments. A proven case study will be presented of strategic sourcing and category management to address significant cost savings, partnerships for product development and launch, and supply risk management.
Speaker
Paul Anderson
Vice President
Global Procurement LifeTechnologies
Track 2 – Tiburon
1:15-1:45 Rewiring the Biotech Supply Chain: The Holy Grail
The best information and systems technology requirements to meet the complex technology needs of the biotech and pharma supply chain community consisting of the manufacturers, distributors, retail pharmacies and hospitals require synchronization, connectivity and sharing of information.
Speakers
Bruce Sawyer
Senior Director, Process Excellence
Johnson & Johnson
Pramod John
Vice President
IT Strategy and Innovation McKesson
Track 3 – Presidio
1:15-1:45 Education Empowering People Excellence and World Class Performance
Widespread APICS education and the process of obtaining Class A certification in manufacturing at Genentech has revolutionized planning and scheduling in biotech plants by meeting demand and decreasing cost of goods at the same time. Two of the key initiatives implemented were APICS education for the planning and scheduling groups, in addition to manufacturing personnel in general, and the quest for Class A certification and world class performance. APICS methodology has been the key to the development of one and two-day classes for senior manufacturing executives and also Class A certification.
Speakers
Keith Launchbury, CFPIM
Past President, APICS The Association for Operations Management
Muffie Dalton, CPIM
Team Leader
Drug Product Plant Scheduling
Genentech
1:45-2:30 PANEL: Combating Cost, Quality, Reliability and Speed to Market in Sourcing Products & Services Globally
Sourcing executives of the industry will present a proven approach for building supplier relations management in the global market place, required organizational structures and responsibilities, strategy to deal with single sourcing, best of breed practices from other industries, information systems for intelligent decision making and cross-disciplinary experiences.
Panelists
Mark Buck
Global Procurement and Supply Leader
Bio-Rad Laboratories
Mike Mitchell
Director
Global Supply Chain Management
SAFC Bioscience
Dale Dwier
Manager
Procurement, Direct Materials
Bayer Healthcare
Isaac Young
Senior Director
Supply Chain Operations
BioMarin Pharmaceuticals
Paul Anderson
Vice President
Global Procurement
Life Technologies
Moderator:
William Coakley
Senior Director
Supply Chain Management
SciClone Pharmaceuticals
1:45-2:15 Pharma Industry Report: 2015 Readiness for Track and Trace
GS1 Healthcare US’s Secure Supply Chain Task Force has developed a pharmaceutical supply chain model as part of a program known as 2015 Readiness. The model is intended to prepare members of the U.S. pharmaceutical supply chain to use a standard serialized track-and-trace system (known as an electronic pedigree) related to the movements of items. Since January 2010, 50 companies have utilized a simulated supply chain to map out a supply chain and send items with unique ID numbers, either on RFID tags or on 2-D bar codes. The program aims to develop a model for anyone in the pharmaceutical industry who is responsible for IT, logistics or packaging, as well as manufacturers, retail pharmacies and wholesalers.
Speaker
Robert Celeste
Director
GS1 Healthcare US
1:45-2:15 PANEL: Meeting the Talent Development Challenges of the Biotech Industry
How best to develop the organization structure, career paths, educational training programs to increase the capabilities and skills to support the growth of the biotech industry remains its greatest challenge. Academicians, human resource personnel for management development, management recruiters and supply chain and operations executives of the industry present successful endeavors in various industries and apply them to biotech.
Panelists
Muffie Dalton
Team Leader
Drug Product Plant Scheduling
Genentech
Phil Kaminsky
Associate Professor
School of IE & OR
UC Berkeley
Adam Zak
CEO
Adam Zak Executive Search
Moderator:
Dave Malenfant
Vice President
Global Supply Chain
Alcon Laboratories
2:30-2:50 The Amplification Effects of Supply Chain Risks to Impact Shareholder Value – How Should this Affect a Business Strategy?
The complexity of today’s supply chain and operational risks can have a profound amplification effect on the ability to supply products to patients or consumers, and quickly erode shareholder value. Industrial situations will be presented to demonstrate how these risks influence long term supply and business strategies.
Speakers
Chris Sam
Executive Director
Craigshannock
(former head of Operations Risk Management, Amgen)
Vijay Chiruvolu
Director
Risk Management
Amgen
2:45-3:15 Mass Serialization for Track & Trace and ePedigree Based on 2D Matrix Code
With the California ePedigree laws implementation date of 2015, now is the time to begin planning for the operational and capital requirements of unit level serialization. What are the requirements? What are the options for meeting them? Learn from our experiences reading 2D Barcodes and exchanging pedigree information. Converting a production line to handle unit level serialization is a time consuming endeavor. Learn from pilot work that has taken place over the past few years what works and the challenges you will face. What are the resources you can draw on going forward?
Speakers
Ron Bone
Senior Vice President
Distribution Support
McKesson
Lew Kontnik
Director
Brand Protection
Amgen
2:15-3:00 PANEL: Implementing ISTA 7E & Standard 20: The First Global Method for Establishing the Performance of ISCs
This session will provide an in-depth look at the rationale and reasoning behind the new set of Global Standards released by the International Transit Authority on September 22nd 2010. ISTA Standard 20 is the first global method for establishing ISC performance and houses the first set of statistically validated global thermal profiles – ISTA 7E Thermal Profiles. ISTA Standard 14 the process by which laboratories can become ISTA Certified to perform ISC testing under the new Standard 20. The panelists will present each standard as they apply to the Industry, Supplier, and Auditor
Panelists
Brian Wallin
Senior Packaging Engineer
Cold Chain Engineering
Amgen
Don Wilson
Senior Engineering Manager
Packaging & Containers
Amgen
Gary Hutchinson
Director
Global Transportation
Amgen
Gordon L. Johnson II
Head of Strategic Innovation
LifeConEx
Jim Cox
MJ Enterprises
ISTA
Moderator:
Rod Derifield
President
Envirocooler
2:50-3:10 Key Learnings from Building a Raw Material Sourcing Risk Management Program
The case study introduces tools, process and general approach in building a raw material risk management program, with a focus on identification of high risk/impact items and implementation of appropriate risk mitigation strategies. Success factors and potential pitfalls in implementing material risk management program will also be discussed.
Speaker
Yingming Yue, CPIM
Associate Director
Supplier Management
Nektar Therapeutics
2:45-3:15 Mass Serialization for Track & Trace and ePedigree Based on 2D Matrix Code
Bayer Healthcare task force has responded to numerous coding initiatives worldwide, e.g. the California Pedigree Law, the European EFPIA initiative, Ministry of Heath requirements in Turkey, France, etc. To comply with the upcoming requirements, a core system based on the 2D Matrix Code has been developed, including packaging line equipment as well as a database system to handle mass serialization.
Speaker
Christian Riediger
Schering Pharma AG
Berlin, Germany
3:00-3:45 PANEL: Future of the Cold Chain Supply Chain: Convergence, Emergence, and Standardization
Presentation of some of the most forward-thinking and innovative thought-leaders in the Industry to provide not only of thoughts and visions of how technology, processes, standards, and products will evolve over the next 20-50 years, but also to identify potential obstacles. The interactive session will enable brain-storming with thought leaders on how we can all join solve the conundrums that lie ahead!
Panelists
Don Wilson
Senior Engineering Manager
Packaging & Containers
Amgen
Gary Hutchinson
Director
Global Transportation
Amgen
Gordon L. Johnson II
Head of Strategic Innovation
LifeConEx
Jim Cox
MJ Enterprises
ISTA
Rod Derifield
President
Envirocooler
3:10-3:30 When Something goes wrong with our supply chain, are we prepared to respond?
This session will explore three different scenarios where in a seemingly small, routine issue snowballs into a supply chain breakdown. Audience participation will be solicited, to derive at a better decision. Large and small companies alike will come away from this risk management exercise with a fresh look at how to be better prepared when something does go wrong.
Speakers
Carla Reed
Principal
Tunnell Consulting
Jane Lavine
Life Sciences RM Consultant
(former VP, Life Science Practice)
Marsh
Mohinder Sikka
CEO
Sensitel
3:15-3:30 2010 Biopharmaceutical Supply Chain Benchmarking Survey Results
Results will be presented of a supply chain assessment of 12 major bio-pharmaceutical companies in the areas of inventory management, delivery performance, cycle times, complexity and cost. The study helps supply chain executives identify the operational levers that needs to be managed, the critical trade-offs that need to be considered in decision-making and the competencies that must be instituted for superior supply chain performances. Key relevant best practices from outside the industry will also be presented.
Speakers
Vitaly Glozman
Director
PRTM Healthcare Practice
Michael Rusignola
Manager
PRTM Healthcare Practice
3:30-4:00 NETWORKING BREAK SPONSORED BY BAYER HEALTHCARE – GOLDEN GATE BALLROOM
4:00-4:45 Panel: Supply Chain Risk Management – Current Practices and Future Focus
Discussion on various initiatives companies are focusing on to manage supply risk. The discussion will be on diverse risk management topics based on the prior presentations and additional feedback
received from the audience.
Panelists
Vijay Chiruvolu
Director
Risk Management
Amgen
Dennis Murphy
Vice-President, Fremont Site
Amgen
Chris Sam
Executive Director
Craigshannock
Thomas Smith
Director
Supply Chain
Shire Pharmaceuticals
Yingming Yue, CPIM
Associate Director
Supplier Management
Nektar Therapeutics
Moderator:
Arun Cavale
Principal
NexInfo
4:00-4:30 CMO/CRO Opportunities in India
The biotechnology industry faces significant issues relating to long gestation periods, high costs of development and manufacturing, regulatory hurdles, diverse competency needs, emerging competition from biosimilars and, above all, funding constraints. Outsourcing addresses many of these issues in functional domains across the value chain, as well as in business domains. Presentation will focus on India which offers several advantages in outsourcing in biotechnology – a large home market enabling scale, less obscure regulatory pathway, a patient pool well-suited to clinical trials, faster time to market in clinical development, access to competencies, competitive contract manufacturing and lower costs, while it has some limitations.
Speaker
K. V. Subramaniam
President & CEO
Reliance Int’l Life Sciences
India
4:00-4:30 Sustainability of the Environment: A Profitable Strategy!
A proactive approach to ensuring sustainability of the environment augurs well for the biotech industry as it has a positive impact on manufacturing and distribution efficiencies, customer service, trading partner relationship, waste disposal and recycling.
Speakers
David Windsheimer
Vice President
Global Logistics
Life Technologies
4:30-5:00 Realizing the Executive S&OP Vision
Risk management is required from the launch of a new product to building a new manufacturing facility and delivering prescription drugs to patients. At every stage, managers have a significant role in assessing, evaluating, and managing risk, using tools and techniques that have been used in other industries and disciplines. Case studies of successful applications will focus on assessment and mitigation of enterprise risk.
Speakers
Jerry Battenber
Vice-President
Beckman Coulter
Arun Cavale
Principal
Nexinfo
4:30-5:00 Improving Cold Chain Visibility
Increasing costs and regulations requires improved cold chain visibility to ensure product integrity. In-transit temperature monitoring provides suppliers, shippers and end users with the info they need to make timely and accurate decisions and create sustainable improvements to reduce waste and costs.
Speaker
Peter Mehring
President and CEO
Intelleflex Corporation
********************
By submitting this form, you are consenting to receive news and event information emails from: Bio Supply Management Alliance (BSMA). You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.
***********************
BSMA SOCIAL COMMUNITY, JOIN US
***********************